Anna Guarini

4.7k total citations
90 papers, 2.6k citations indexed

About

Anna Guarini is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Guarini has authored 90 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 42 papers in Immunology and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Guarini's work include Chronic Lymphocytic Leukemia Research (42 papers), Lymphoma Diagnosis and Treatment (32 papers) and Acute Lymphoblastic Leukemia research (27 papers). Anna Guarini is often cited by papers focused on Chronic Lymphocytic Leukemia Research (42 papers), Lymphoma Diagnosis and Treatment (32 papers) and Acute Lymphoblastic Leukemia research (27 papers). Anna Guarini collaborates with scholars based in Italy, United States and Germany. Anna Guarini's co-authors include Robin Foà, R. Foà, Sabina Chiaretti, Antonella Vitale, Francesca Romana Mauro, Massimo Massaia, Angela Santoni, S Cardona, Robert Foà and Bernd Gänsbacher and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

Anna Guarini

88 papers receiving 2.6k citations

Peers

Countries citing papers authored by Anna Guarini

Since Specialization

Citations

This map shows the geographic impact of Anna Guarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Guarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Guarini more than expected).

Fields of papers citing papers by Anna Guarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Guarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Guarini. The network helps show where Anna Guarini may publish in the future.

Co-authorship network of co-authors of Anna Guarini

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Guarini. A scholar is included among the top collaborators of Anna Guarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Guarini. Anna Guarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma 2024 ·Haematologica ·(unknown), (unknown), Irene Della Starza, Riccardo Moia, (unknown), (unknown), (unknown), (unknown), Luigi Petrucci, Gianluca Gaïdano, Anna Guarini, Maurizio Martelli, Alice Di Rocco, Robin Foà, Ilaria Del Giudice	2
2	Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies? 2023 ·Frontiers in Oncology ·(unknown), Ilaria Del Giudice, Irene Della Starza, (unknown), Marzia Cavalli, (unknown), (unknown), (unknown), Anna Guarini, Robin Foà	1
3	Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity 2023 ·Cancers ·Alessandro Natoni, (unknown), Maria Stefania De Propris, Maria Teresa Petrucci, Francesca Fazio, (unknown), Maria Laura Milani, (unknown), Robert B. Henderson, Dawn Swan, Anna Guarini, Michael O’Dwyer, Robin Foà	6
4	Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia 2023 ·Cancers ·Irene Della Starza, Lucia Anna De Novi, Loredana Elia, (unknown), (unknown), (unknown), (unknown), Sabina Chiaretti, Anna Guarini, Robin Foà	12
5	Sialylation regulates migration in chronic lymphocytic leukemia 2023 ·Haematologica ·Alessandro Natoni, (unknown), Maria Stefania De Propris, Ilaria Del Giudice, (unknown), Nadia Peragine, (unknown), Maria Laura Milani, Anna Guarini, Robin Foà	9
6	Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia 2021 ·Hematological Oncology ·Michela Ansuinelli, Irene Della Starza, (unknown), Loredana Elia, (unknown), Monica Messina, Lucia Anna De Novi, (unknown), Martina Canichella, Anna Guarini, Robin Foà, Sabina Chiaretti	16
7	Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia 2018 ·Blood ·Irene Della Starza, (unknown), Federica Lovisa, Daniela Silvestri, Marzia Cavalli, Andrea Garofalo, (unknown), Lucia Anna De Novi, (unknown), Andrea Biondi, Anna Guarini, Maria Grazia Valsecchi, Valentino Conter, Giuseppe Basso, Robin Foà, Giovanni Cazzaniga	4
8	Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia 2014 ·Blood ·Davide Rossi, Hossein Khiabanian, Valeria Spina, Carmela Ciardullo, Alessio Bruscaggin, Rosella Famà, Silvia Rasi, Sara Monti, Clara Deambrogi, Lorenzo De Paoli, Jiguang Wang, Valter Gattei, Anna Guarini, Robin Foà, Raúl Rabadán, Gianluca Gaïdano	228
9	Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients 2014 ·Cancer Immunology Immunotherapy ·Nadia Peragine, G Torelli, (unknown), (unknown), Antonella Vitale, Anna Guarini, Robin Foà	14
10	Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 2011 ·Leukemia & lymphoma ·Sara Raponi, Maria Stefania De Propris, (unknown), Maria Laura Milani, Antonella Vitale, Loredana Elia, Omar Perbellini, Giovanni Pizzolo, Robin Foà, Anna Guarini	164
11	Histopathological and molecular features of persistent polyclonal B‐cell lymphocytosis (PPBL) with progressive splenomegaly 2009 ·British Journal of Haematology ·Ilaria Del Giudice, Stefano Pileri, Maura Rossi, Elena Sabattini, Cristina Campidelli, Irene Della Starza, M. S. De Propris, Francesca Mancini, Maria Paola Perrone, (unknown), Daniele Armiento, (unknown), Agostino Tafuri, Angela Amendola, Francesca Romana Mauro, Anna Guarini, Robin Foà	19
12	Defective expression of the T‐cell receptor‐CD3 ζ chain in T‐cell acute lymphoblastic leukaemia 2003 ·British Journal of Haematology ·G Torelli, Rossella Paolini, Caterina Tatarelli, Alessandra Soriani, Antonella Vitale, Anna Guarini, Angela Santoni, Robin Foà	20
13	Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission 2002 ·British Journal of Haematology ·G Torelli, Anna Guarini, Gabriella Palmieri, Massimo Breccia, Antonella Vitale, Angela Santoni, Robin Foà	18
14	Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission 2002 ·British Journal of Haematology ·G Torelli, Anna Guarini, Gabriella Palmieri, Massimo Breccia, Antonella Vitale, Angela Santoni, Robin Foà	21
15	Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder 1999 ·British Journal of Cancer ·Michele Stanislaw Milella, Jordan Jacobelli, Federica Cavallo, Anna Guarini, Francesca Velotti, Luigi Frati, Robin Foà, G Forni, Angela Santoni	12
16	Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings. 1992 ·PubMed ·(unknown), Giovanna Meloni, Anna Guarini, Marco Vignetti, Gian Marco De Marchis, S. Tosti, Anna Gillio‐Tos, (unknown), Franco Mandelli, F Gavosto	3
17	Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic Leukemia 1991 ·Leukemia & lymphoma ·Robin Foà, (unknown), Massimo Pini, F. Lauria, Anna Guarini	4
18	Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin 1990 ·British Journal of Haematology ·Robin Foà, (unknown), Maria Teresa Fierro, Margherita Bonferroni, S Cardona, Anna Guarini, Patrizia Lista, Luigi Pegoraro, Franco Mandelli, G Forni, F Gavosto	41
19	The inhibitory effect of serum from hairy‐cell leukaemia patients on normal progenitor cells may disappear following prolonged treatment with α‐interferon 1989 ·British Journal of Haematology ·F. Lauria, Gian Paolo Bagnara, Lucia Catani, (unknown), Anna Guarini, Donatella Raspadori, Robert Foà, Graziella Bellone, Marina Buzzi, Luigi Gugliotta, Giorgio Zauli, Marco Giovannini, Pier Luigi Zinzani, S Tura	15
20	Human myeloid precursor cells do not possess or produce procoagulant activity (PCA). 1986 ·PubMed ·Anna Guarini, L Gugliotta, (unknown), (unknown), (unknown), (unknown), (unknown), Lucia Catani, (unknown), S Tura	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact